Study validates disc diffusion test for poultry Salmonella vaccine strains

A newly published study in Veterinary Sciences says a disc diffusion method can reliably differentiate a bivalent live Salmonella vaccine from field strains, with validation carried out across multiple suppliers. The work addresses a familiar challenge in poultry medicine: once live Salmonella vaccines are used in breeding or laying flocks, routine monitoring can detect vaccine-derived organisms, creating uncertainty about whether a positive result reflects expected post-vaccination shedding or a true field infection. (vmd.defra.gov.uk)

That distinction matters because live vaccination has become an important part of Salmonella control in poultry, especially for Salmonella Enteritidis and Salmonella Typhimurium, two serovars closely tied to human foodborne illness through eggs and poultry meat. The UK product characteristics for SALMOVAC 440, for example, state that the vaccine is indicated to reduce colonization, persistence, and invasion by S. Enteritidis and S. Typhimurium in chickens, but also note that vaccinated birds may excrete the vaccine strain for up to six weeks after vaccination. The same filing says the strain is a double-attenuated adenine-histidine auxotroph, a feature used for differentiation from wild strains. (vmd.defra.gov.uk)

The broader diagnostic need is well established in the literature. A 2024 research note on an alternative differentiation approach for the 441/014 vaccine strain said labs, veterinarians, producers, and authorities all need definitive answers quickly, particularly in layers, because eggs may not be marketable until the isolate is identified as vaccine or field strain. That paper found complete agreement between three methods for identifying the vaccine strain and highlighted the value of simpler workflows that shorten turnaround time. (pmc.ncbi.nlm.nih.gov)

Recent work in adjacent products points the same way. A 2025 Applied Sciences paper validating a duplex qPCR assay for the Primun Salmonella T vaccine argued that misclassifying a wild strain as vaccine could delay outbreak response, while misclassifying a vaccine strain as wild could trigger unnecessary culling and economic loss. The authors also noted that older differentiation strategies based on antimicrobial resistance profiles may become less dependable as resistance patterns in field strains change. That context helps explain why a low-complexity, phenotypic method such as disc diffusion would draw interest if it performs consistently across suppliers. (mdpi.com)

I didn’t find a separate company press release or broad industry reaction tied specifically to this new Veterinary Sciences paper. But the surrounding literature suggests the field is actively looking for practical DIVA-style tools that fit routine surveillance, not just high-complexity molecular assays. Published alternatives already include PCR kits and chromogenic media approaches, and at least one such method has been incorporated by Spain’s medicines agency for differentiation of the 441/014 vaccine strain. (pmc.ncbi.nlm.nih.gov)

Why it matters: For veterinary professionals working with poultry systems, this is less about one laboratory technique and more about decision quality. When a flock screens positive for Salmonella, the next question drives everything that follows: Is this a vaccine strain, or a field strain with food safety implications? A validated, supplier-independent disc diffusion method could help standardize interpretation across labs, reduce unnecessary disruption, and support more confident conversations with integrators, regulators, and pet parents who are increasingly attentive to food safety and antimicrobial stewardship. It could also be especially useful in settings where PCR capacity is limited or where labs want a lower-cost screen before reflex molecular testing. That last point is an inference based on the method type and the operational pressures described in related studies. (pmc.ncbi.nlm.nih.gov)

What to watch: The next step is whether independent labs, poultry health networks, or regulatory bodies reference this method in routine surveillance guidance, and whether it proves robust enough to sit alongside PCR and chromogenic media in real-world outbreak investigations. I found the primary study context and supporting background on vaccine differentiation, but I didn’t find a dedicated press release or outside expert quote specifically discussing this paper, so the industry reaction appears limited or not yet widely published. (pmc.ncbi.nlm.nih.gov)